Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCorero Network Regulatory News (CNS)

Share Price Information for Corero Network (CNS)

Share Price is delayed by 15 minutes
Get Live Data
11.25    0.00 (0.00%)
Bid:
11.00
Ask:
11.50
Spread: 0.50 (4.545%)
Market Cap: £57.62m
CNS Live PriceLast checked at - London Stock Exchange

Intraday Corero Network Share Chart

Contract Win

12 Dec 2006 07:02

Mondas PLC12 December 2006 Mondas plc ("Mondas") Mondas signs new contract for Blue Curve. Mondas plc, the AIM listed Financial Markets software specialist has secured anorder to supply Ingenious Securities Limited with its market leading Blue Curveresearch management software solution. The contract is for the supply oflicences, professional services and support. Mondas will provide Ingenious Securities with the complete Blue Curve suite ofmodules, consisting of insight, create, process, comply and reach products thatwill facilitate the production and distribution of Ingenious Securities researchproducts at optimum levels of quality and efficiency. Ingenious Securities expects the software to allow it to improve customerservice, gain significant production efficiencies and quickly expand the rangeand complexity of its research offerings. The project will begin immediately with a phased approach, the first of which isdue to go live early next year. Jarlath McGee, Chief Executive of Mondas said. "Blue Curve is now the solutionof choice for many financial institutions and this is yet another example of thetremendously exciting success the division has recently enjoyed." "We lookforward to working with Ingenious Securities to build and operate a highlyefficient research production platform that will bring them significantoperational benefits." Richard Jeffrey, Head of Securities said "The Media sector creates significantopportunities for Ingenious Securities and we intend to offer our clients a fullbreadth and depth of research. Therefore, having a reliable and effectivesolution like Blue Curve in place will be a major step towards achieving thatgoal and supporting the ongoing rapid growth of our business." Mark Robertson, director, Mondas financial markets division commented: "I amdelighted that Ingenious Securities, a new securities business focused on themedia sector has selected Mondas and placed its trust in the Blue Curve solutionfor this very exciting and important project. This major new contract to providespecialist advice and an effective software platform to support a rapidlychanging sector underlines the wide market appeal of the Blue Curve solution." ENQUIRIES: Mondas PLC Tel: 020 7392 1300Jarlath McGee (chief executive) College Hill Tel: 020 7457 2020Matthew Smallwood Mondas Plc: Mondas Financial Markets Division focuses on delivering asset-servicingsolutions for global corporate actions processing, financial research, clientreporting and the management of new issues and placings. Its key productsinclude Radica CAPS, Signal, Venture and the Blue Curve suite of products. Blue Curve Blue Curve, founded in 1995 and acquired by Mondas in 2006, designs, builds anddeploys enterprise solutions that improve the production and distribution ofcomplex financial documents. The Blue Curve solution is the recognised leader insoftware applications that improve the production and distribution of investmentresearch. For more information, see http://www.bluecurve.net Ingenious Securities: Ingenious Securities is the latest addition to the Ingenious group of companies,with an anticipated formal launch set for the first quarter of 2007. IngeniousSecurities' core offering will be the provision of a specialist research productthat is focused predominantly on the media sector. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Jul 20107:19 amPRNDisposal, fund raising and directorate change
12th Jul 20107:00 amPRNAdviser - Change of Name
19th May 20102:41 pmPRNResult of AGM
11th May 20107:00 amRNSContract Win
21st Apr 20107:00 amRNSContract Win
30th Mar 20107:00 amPRNHolding(s) in Company
26th Mar 20107:00 amPRNFinal Results
19th Mar 20107:00 amRNSContract Win
26th Jan 20107:00 amPRNTrading Statement
16th Oct 20097:00 amPRNMajor Contract Extension
15th Oct 20097:01 amPRNNOMAD Change of Name
18th Sep 20091:39 pmPRNDirector/PDMR Shareholding
17th Sep 20097:00 amPRNHalf-yearly Report
30th Jun 20094:03 pmPRNTotal Voting Rights
29th Jun 20093:27 pmPRNResult of Meeting
4th Jun 20097:00 amPRNAmendment to the CULS and Capital Reorganisation
26th Mar 20097:00 amPRNFinal Results
20th Jan 20097:00 amPRNTrading Statement
8th Aug 20087:00 amPRNHalf-yearly Report
21st May 20083:33 pmRNSResults of Meeting
19th May 20082:02 pmPRNDirectorate Change
31st Mar 200811:58 amPRNGrant of Options
25th Mar 20085:09 pmPRNDirector/PDMR Shareholding
20th Mar 20087:00 amPRNFinal Results
23rd Nov 20074:24 pmPRNDirector/PDMR Shareholding
23rd Nov 20077:00 amPRNTrading Statement and Board Changes
6th Nov 200710:52 amPRNHolding(s) in Company
6th Nov 20077:01 amRNSNew Contract for Blue Curve
27th Sep 20077:01 amRNSInterim Results
24th Sep 200710:30 amPRNChange of Registered Office
14th Aug 20077:01 amRNSContract Win
10th Aug 20073:39 pmPRNAIM Rule 26
2nd Aug 20077:02 amRNSContract Wins
27th Jul 200712:52 pmPRNDirector/PDMR Shareholding
26th Jul 20077:00 amPRNDirectorate Change and Trading Update
9th Jul 20074:35 pmPRNHolding(s) in Company
3rd Jul 20077:01 amRNSContract win
24th May 20072:50 pmPRNResult of AGM
30th Apr 20073:57 pmPRNTotal Voting Rights
25th Apr 20073:47 pmPRNHolding(s) in Company
24th Apr 200710:02 amPRNHolding(s) in Company
23rd Apr 20073:23 pmPRNHolding(s) in Company
3rd Apr 20075:25 pmPRNIssue of Equity
29th Mar 20077:01 amRNSFinal Results
27th Feb 200710:59 amPRNResult of EGM
2nd Feb 20073:34 pmRNSFurther re Change of Name
18th Jan 20077:01 amRNSChange of Name
12th Jan 20079:41 amPRNHolding(s) in Company
3rd Jan 20077:00 amRNSContracts, Trading Update
22nd Dec 200610:41 amPRNTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.